Acumen Pharmaceuticals Other Current Assets Over Time
| ABOS Stock | USD 2.20 0.06 2.65% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Acumen Pharmaceuticals Performance and Acumen Pharmaceuticals Correlation. Acumen |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share 0.033 | Return On Assets (0.21) | Return On Equity (0.33) |
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acumen Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Assets Analysis
Compare Acumen Pharmaceuticals and related stocks such as Terns Pharmaceuticals, X4 Pharmaceuticals, and Day One Biopharmaceu Other Current Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TERN | 162 K | 162 K | 162 K | 162 K | 162 K | 162 K | 162 K | 162 K | 162 K | 461 K | 3.3 M | 1.9 M | 2.1 M | 4 M | 2.2 M |
| XFOR | 87 K | 87 K | 87 K | 87 K | 87 K | 87 K | 90 K | 2.1 M | 1.5 M | 1.1 M | 3.7 M | 5.3 M | 5.8 M | 7.3 M | 7.7 M |
| DAWN | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 1.3 M | 5.1 M | 5.6 M | 8.9 M | 4.6 M |
| HOOK | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 8.8 M | 13.3 M | 8.1 M | 15 M | 12.7 M | 10.7 M | 11.1 M |
| INZY | 73 K | 73 K | 73 K | 73 K | 73 K | 73 K | 73 K | 73 K | 73 K | 224 K | 3.3 M | 3.5 M | 3.4 M | 7.3 M | 7.6 M |
| MREO | 253.9 K | 253.9 K | 253.9 K | 253.9 K | 253.9 K | 253.9 K | 55 M | 4.5 M | 1.4 M | 14.1 M | 1.6 M | 5 M | 4.3 M | 2.6 M | 2.5 M |
Acumen Pharmaceuticals and related stocks such as Terns Pharmaceuticals, X4 Pharmaceuticals, and Day One Biopharmaceu Other Current Assets description
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.My Equities
My Current Equities and Potential Positions
| Acumen Pharmaceuticals | ABOS |
| Classification | Biotech |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.2
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.